Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: a Pivotal Randomized Double Masked Placebo Controlled Study

Trial Profile

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: a Pivotal Randomized Double Masked Placebo Controlled Study

Status: Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 06 Mar 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Biotin (Primary)
  • Indications Multiple sclerosis; Optic neuritis
  • Focus Registrational; Therapeutic Use
  • Acronyms MS-ON
  • Sponsors MedDay Pharmaceuticals
  • Most Recent Events

    • 28 May 2018 Results evaluating whether MD1003 improves vision compared with placebopublished in the CNS Drugs
    • 23 Mar 2017 Planned End Date changed from 1 Jan 2016 to 1 Jan 2018.
    • 21 Apr 2016 According to a MedDay media release, full results of this trial were presented at the American Academy of Neurology Annual Meeting 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top